IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.42
Bid: 4.42
Ask: 4.46
Change: 0.02 (0.45%)
Spread: 0.04 (0.905%)
Open: 4.515
High: 4.515
Low: 4.38
Prev. Close: 4.40
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant Approval

14 Aug 2006 10:57

Seeing Machines Limited14 August 2006 14 August 2006 SEEING MACHINES LIMITED ("Seeing Machines" or "the Company") AUSTRALIAN GOVERNMENT APPROVES GRANT APPLICATION Seeing Machines Limited (AIM: SEE), a leading developer of advanced computerbased imaging software systems, has been advised by AusIndustry that itsapplication for an Australian Federal Government Commercial Ready Grantsupporting its glaucoma diagnostic device development project has been approved,conditional on finalising normal contractual arrangements. The grant providesmatching funding of up to AUD$2.1 million over 2 years to support the continueddevelopment and commercialization of the glaucoma device. Seeing Machines' glaucoma device is a non-contact objective device designed toreliably and quickly measure a person's functional visual field. Assessingvisual field is crucial in diagnosing a range of human visual system diseases,such as glaucoma. The key advantages the Seeing Machines device has over thoseavailable on the market today are derived from the objectivity of the technique.It is non-contact, fast and greatly enhances the patient experience. Seeing Machines completed an initial research and development project for thedevice in February 2006 and this work was supported by a $250,000 AusIndustryBiotechnology Innovation Fund Grant. The company has successfully completed(June 2006) a $3.2 million R&D Start Grant project aimed at developing SeeingMachines' face and eye tracking technology to a level where deployment in theautomotive domain for the detection of fatigue and distraction is feasible. Seeing Machines CEO Nick Cerneaz said: "the Company was very pleased to beawarded the Commercial Ready Grant. The strong endorsement of our technology, R&D capabilities and the potential for successful commercialisation of thisdevice is very encouraging." He also commented on the importance of governmentprograms supporting innovation for local industry development and noted thestrong support the company had received over the years for its R&D both fromCommonwealth and local government programs. Federal Industry Minister Ian Macfarlane congratulated Seeing Machines on beingoffered the Australian Government Commercial Ready grant to develop the devicethat will make it easier to diagnose diseases affecting vision: "Diseases such as glaucoma afflict millions of people world-wide and it isdifficult to detect. Seeing Machines has a strong track record in developingtechnology in this field and the Government, through the Commercial Readyprogram, is pleased to support projects such as this." Enquiries:Seeing Machines Limited Insinger de Beaufort Parkgreen Communications Nick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Jun 20247:00 amRNSFive year License Renewal with Caterpillar
7th May 20247:00 amRNSQ3 FY2024 Quarterly KPIs
2nd May 202410:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSAutomotive Program Extension to 2032
26th Apr 202411:00 amRNSDirector/PDMR Shareholding
25th Mar 20248:06 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSHalf year results and financial report
28th Feb 20247:00 amRNSNotice of Results
8th Feb 20247:00 amRNSH1 FY2024 Trading Update & Quarterly KPIs
10th Jan 20247:00 amRNSNew Orders for Guardian Generation 3
9th Jan 20247:00 amRNSSeeing Machines unveils latest Guardian technology
3rd Jan 20247:00 amRNSSeeing Machines to showcase technology at CES 2024
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.